Covid-19 shutdown led to increased solar power output
Shutdowns in response to the Covid-19 pandemic have resulted in lowered air pollution levels around the world.
Researchers at MIT, and in Germany and...
Your high blood pressure drug and COVID-19: What you need to know
If you have high blood pressure you may have heard that certain medications could put you at higher risk for COVID-19 complications, but one...
These two drugs may strongly reduce deaths in COVID-19
In a new study, researchers found a new way to treat patients with COVID-19-associated Cytokine storm syndrome (CSS).
They found that a treatment strategy combining...
These 3 things combined together can prevent COVID-19 best
In a new study, researchers found both self-imposed prevention measures such as hand-washing, mask-wearing and social distancing, as well as government-imposed social distancing can...
Scientists find surprising heart damage in people with COVID-19
In a new study, researchers found the damage to the hearts of COVID-19 patients is not the expected typical inflammation of the heart muscle,...
Scientists find different COVID-19 skin symptoms
In a new study, researchers found skin signs of COVID-19 can range from purple toes, known as "COVID toes" seen in patients with mild...
Asymptomatic spread could make the COVID-19 pandemic longer and worse
In a new study, researchers found the asymptomatic spread of the coronavirus is likely both common and significant.
The finding may help dispel lingering doubts...
A better way to prevent COVID-19 than face masks: Face shields
A recent study from the University of Iowa found that face shields might replace masks as a more comfortable and more effective deterrent to...
This new sensor may detect COVID-19 in the air much faster
In a new study, researchers have developed a new sensor that could detect COVID-19 particles in the air fast.
The research was conducted by a...
UK’s vaccine against COVID-19 is safe and promising, study finds
In a new study, researchers report promising early-stage results from a phase 1/2 clinical trial of the UK's vaccine candidate against SARS-CoV-2 (the virus...